Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hopkins Capital Group is a healthcare-focused venture capital and private equity firm based in Chesterfield, Missouri. Founded in 1990 by Dr. Francis E. O'Donnell, Jr., the firm specializes in seed and early-stage investments within the biotechnology, specialty pharmaceuticals, and medical technology sectors. Hopkins Capital Group often takes an active role in its portfolio companies, which have included Accentia Biopharmaceuticals, Biovest International, and Treos Bio. The firm's investment strategy emphasizes the development of innovative drug delivery technologies and therapies for unmet medical needs in oncology, respiratory health, and chronic pain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hopkins Capital Group.